Journals / Muş Alparslan Üniversitesi Fen Bilimleri Dergisi / 2026 / Cilt: 13 Sayı: 1

Investigation of Antiproliferative Effects of Heracleum persicum Extracts on Glioblastoma Multiforme Cell Line

Heracleum persicum Ekstraktlarının Glioblastoma Multiforme Hücre Hattı Üzerindeki Antiproliferatif Etkilerinin Araştırılması

Kemal Alp Nalcı(VAN YUZUNCU YIL UNIVERSITY)0000-0003-3786-5246
Leyla Güven(ATATÜRK ÜNİVERSİTESİ)0000-0002-3189-6415
Ravza Manto(VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ)0000-0001-5983-9909
Nefise Şentürk(VAN YUZUNCU YIL UNIVERSITY)0000-0002-8776-522X
Umut Furkan Bayram(VAN YUZUNCU YIL UNIVERSITY)0009-0008-7836-8469
Adnan Çetin(Van Yuzuncu Yıl University)0000-0003-4838-1503
Pages
64–69
Publication Date
2025-06-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that at a concentration of 10⁻¹ mg/mL for 24 hours, the leaf and root extracts caused cell death at rates of 76% and 81%, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heracleum persicum (H. percium) is a plant known for its anti-inflammatory, analgesic, anticonvulsant, and antioxidant properties.
📊
Key Findings & Data:In this study, the antiproliferative effects of the ethanolic leaf and root extracts of the plant on the human Glioblastoma Multiforme U-87MG cell line were evaluated.
💡
Conclusion & Impact:The results showed that at a concentration of 10⁻¹ mg/mL for 24 hours, the leaf and root extracts caused cell death at rates of 76% and 81%, respectively.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:: Antiproliferatif etki · Bitki ekstraktları · Glioblastoma multiforme

Abstract

Heracleum persicum (H. percium) is a plant known for its anti-inflammatory, analgesic, anticonvulsant, and antioxidant properties. In this study, the antiproliferative effects of the ethanolic leaf and root extracts of the plant on the human Glioblastoma Multiforme U-87MG cell line were evaluated. The leaf and root extracts were applied at concentrations of 10⁻¹, 10⁻², 10⁻³, 10⁻⁴, 10⁻⁵, and 10⁻⁶ mg/mL for 24 and 72 hours, and cell viability was determined using the MTT assay. The results showed that at a concentration of 10⁻¹ mg/mL for 24 hours, the leaf and root extracts caused cell death at rates of 76% and 81%, respectively. In the 72-hour application, the leaf extract at a concentration of 10⁻¹ mg/mL led to 83% cell death, while the root extract at the same concentration caused 92% cell death. These findings demonstrate that H. persicum extracts exhibit antiproliferative effects on the U-87MG cell line and suggest their potential as therapeutic agents.

Özet

Heracleum persicum (H. percium), anti-inflamatuvar, analjezik, antikonvülzan ve antioksidan özellikleriyle bilinen bir bitkidir. Bu çalışmada, bitkinin etanolik yaprak ve kök ekstrelerinin insan Glioblastoma Multiforme U-87MG hücre hattı üzerindeki antiproliferatif etkileri değerlendirildi. Yaprak ve kök ekstreleri 10⁻¹, 10⁻², 10⁻³, 10⁻⁴, 10⁻⁵ ve 10⁻⁶ mg/mL konsantrasyonlarında 24 ve 72 saat süreyle uygulanarak hücre canlılıkları MTT testi ile belirlendi. Sonuçlar, 10⁻¹ mg/mL konsantrasyonunda 24 saatte yaprak ve kök ekstrelerinin sırasıyla %76 ve %81 oranında hücre ölümüne neden olduğunu gösterdi. 72 saatlik uygulamada, yaprak ekstresinin 10⁻¹ mg/mL konsantrasyonu %83 oranında hücre ölümüne yol açarken, kök ekstresinin 10⁻¹ mg/mL konsantrasyonu %92 oranında hücre ölümüne neden oldu. Bu bulgular, H. persicum ekstrelerinin U-87MG hücre hattında antiproliferatif etki gösterdiğini ve potansiyel terapötik ajanlar olarak değerlendirilebileceğini ortaya koymaktadır.

🔖

Cite This Article

Nalcı, K. A., Güven, L., Manto, R., Şentürk, N., Dervişoğlu, G., Ozdemir, F. A., Bayram, U. F., Yılmaz, M. E., Yöndeş, S. N., Çetin, A. (2025). Investigation of Antiproliferative Effects of Heracleum persicum Extracts on Glioblastoma Multiforme Cell Line. Muş Alparslan Üniversitesi Fen Bilimleri Dergisi, Cilt: 13 Sayı: 1, 64–69. https://doi.org/10.18586/msufbd.1660341

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Keskin, E., Elmas, Ö., Aydin, H.A., Şimşek, K., Gün, E., Kalaycı, M. Glioblastome Multiforme Epidemiyolojisi, Tedavi Seçenekleri ve Sağ Kalım Süresi: Retrospektif Tek Merkezli Çalışma, Batı Karadeniz Tıp Dergisi, 5:2 248-255, 2021.[2] Brem, S., Abdullah, K.G. Glioblastoma E- Book. Elsevier Health Sciences, 1 87, 2016.
  2. Sanli, A.M., Turkoglu, E., Dolgun, H., Sekerci, Z. Unusual manifestations of primary Glioblastoma Multiforme: A report of three cases, Surgical neurology international, 2010.
  3. Alifieris, C., Trafalis, D.T. Glioblastoma multiforme: Pathogenesis and treatment, Pharmacology & therapeutics, 152 63-82, 2015.
  4. Mann, J., Ramakrishna, R., Magge, R., Wernicke, A.G. Advances in radiotherapy for glioblastoma, Frontiers in neurology, 8 748, 2018.
  5. Shergalis, A., Bankhead III, A., Luesakul, U., Muangsin, N., Neamati, N. Current challenges and opportunities in treating glioblastoma, Pharmacological reviews, 70:3 412-445, 2018.
  6. Omuro, A., DeAngelis, L.M. Glioblastoma and other malignant gliomas: a clinical review. Jama, 310:17 1842-1850, 2013.
  7. Cragg.G.M., Newman, D.J. Natural products: a continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA)-General Subjects, 1830:6 3670-3695, 2013.
  8. Bozkurt, E., Atmaca, H., Uzunoğlu, S., Glioblastoma tümörlerinde çoklu ilaç direnci, Genel Tıp Dergisi, 23:4 133-143, 2013.
  9. Taghizadehghalehjoughi, A., Hacimuftuoglu, A., Cetin, M., Ugur, A.B., Galateanu, B., Mezhuev, Y., Okkay, U., Taspinar N., Uyanik, A., Gundogdu, B., Mohammadzadeh, M., Nalci, K.A., Stivaktakis, P., Tsaktakis, A., Jung, T.W., Jeong, J.H., El-Aty, A. A. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: In vitro and in vivo studies, Nanomedicine, 13:13 1595-1606, 2018.
  10. Sarkaria, J.N., Hu, L.S., Parney, I.F., Pafundi, D.H., Brinkmann, D.H., Laack, N.N., Giannini, C., Burns, T.C., Kizilbash, S.H., Laramy, J.K., Swanson, K.R., Kaufmann, T.J., Brown, P.D., Agar, N.Y.R., Galanis, E., Buckner, E., Elmquist, W.F. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro-oncology, 20:2 184-191, 2018.
  11. Shahcheraghi, S.H., Zangui, M., Lotfi, M., Ghayour-Mobarhan, M., Ghorbani, A., Jaliani, H.Z., Sadeghnia, H.R., Sahebkar, A., Therapeutic potential of curcumin in the treatment of glioblastoma multiforme, Current pharmaceutical design, 25:3 333-342, 2019.
  12. Tavana, E., Mollazadeh, H., Mohtashami, E., Modaresi, S.M.S., Hosseini, A., Sabri, H., Soltani, A., Javid, H., Afshari, A.R., Sahebkar, A. Quercetin: a promising phytochemical for the treatment of glioblastoma multiforme, BioFactors, 46:3 356-366, 2020.
  13. Hajhashemi, V., Sajjadi, S.E., Heshmati, M. Anti-inflammatory and analgesic properties of Heracleum persicum essential oil and hydroalcoholic extract in animal models, J Ethnopharmacol, 124:3 475-480, 2009.
  14. Sayyah, M., Moaied, S., Kamalinejad, M. Anticonvulsant activity of Heracleum persicum seed, J Ethnopharmacol, 96 209-211, 2005.
  15. Zheleva-Dimitrova, D., Sinan, K.I., Etienne, O. K., Ak, G., Sharmeen, J.B., Dervisoglu, G., Ozdemir, F.A., Mahomoodally, M.F., Zengin, G. Comprehensive chemical characterization and biological evaluation of two Acacia species: A. nilotica and A. ataxacantha, Food and Chemical Toxicology, 156 112446, 2021.
  16. Dervisoglu G., Anticancer effects of sodium selenate in human neuroblastoma, breast cancer, and melanoma cells, International Journal of Secondary Metabolite, 12:1 225-234, 2025.
  17. Maddigan, A., Truitt, L., Arsenault, R., Freywald, T., Allonby, O., Dean, J., Narendran, A., Xiang, J., Weng, A., Napper, A., Freywald, A. EphB Receptors Trigger Akt Activation and Suppress Fas Receptor-Induced Apoptosis in Malignant T Lymphocytes, Journal of immunology, 187:11 5983-5994, 2011.
  18. Demirkaya, A., Gündoğdu, G., Karakaya, S., Yilmaz Taşci, Ş., Nalcı, K., Hacimüftüoğlu, A. Does umbelliferone protect primary cortical neuron cells against glutamate excitotoxicity?, Kafkas Universitesi Veteriner Fakultesi Dergisi, 27:3 2021.
  19. Nalcı, K.A., Mete, C., Demir, Z., Bildirici, İ., Cetin, A. Promising Anticancer Activity of Pyrazole Compounds against Glioblastoma Multiforme: Their Synthesis, In vitro, and Molecular Docking Studies, Medicinal chemistry, 2025
  20. Çelik, N., Işcan Yapar, M., Taghizadehghalehjoughi, A., Nalcı, K. A. Influence of resveratrol application with pulp-capping materials on the genetic expression levels of stem cells, International Endodontic Journal, 53:9 1253-1263, 2020.
  21. Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., Simjee, S.U. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment, Asian Pacific journal of cancer prevention,18:1 3, 2017.
  22. Majidi, Z., Lamardi, S.S. Phytochemistry and biological activities of Heracleum persicum: a review," Journal of Integrative Medicine, 16:4 223-235, 2018.
  23. Präbst, K., Engelhardt, H., Ringgeler, S., Hübner, H. Basic colorimetric proliferation assays: MTT, WST, and resazurin, Cell viability assays: methods and protocols, 1-17, 2017.
  24. Gavanji, S., Bakhtari, A., Famurewa, A.C., Othman, E.M. Cytotoxic Activity of Herbal Medicines as Assessed in Vitro: A Review, Chemistry & Biodiversity, 20:2 e202201098, 2023.
  25. Majidi, Z., Lamardi, S.S. Phytochemistry and biological activities of Heracleum persicum: a review," Journal of Integrative Medicine, 16:4 223-235, 2018.